| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |